Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8247226 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 12 Pages |
Abstract
Conclusion: Clearly, there is an unmet need for safer agents that augment the efficacy of radiation therapy. This review highlights five promising redox modulators that are in development. None has yet been approved by the Food and Drug Administration. These drugs were selected for discussion because they exemplify the current investigative landscape of radiosensitizers and are indicative of future directions in this area. These radiation sensitizers have the potential to succeed where others have failed, by locally increasing the radiosensitivity of tumor cells without enhancing that of surrounding normal tissues.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Abby B.A., Susan Ph.D., M.D.,